Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay
NCT ID: NCT02167113
Last Updated: 2018-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
331 participants
OBSERVATIONAL
2014-03-31
2018-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B
NCT00116805
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B
NCT03109730
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
NCT03577171
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
NCT00524173
Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear Cells
NCT05168293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study population
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject will be considered treatment naïve if he/she had \<12 weeks of oral antiviral therapy with any nucleoside or nucleotide therapy
* The subject is at least 18 years of age at the time of enrollment
* Adequate medical records are available for collection of protocol-defined demographics, baseline patient characteristics, medical history, virology and specific laboratory results, and other information to verify enrollment criteria
* The subject and/or legally authorized representative is willing and able to provide consent prior to providing a specimen(s)
Exclusion Criteria
* Acute HBV infection
* Patients who are HBV immune tolerant
* Human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) co-infection
* Solid organ or bone marrow transplant recipients
* Renal failure or dialysis
* Evidence or history of hepatic decompensation
* Evidence or history of hepatocellular carcinoma
* Underlying liver disease other than HBV
* Receiving chemotherapy, immunosuppressive agents
* Subject is unsuitable for study participation based on the Investigator's decision (eg, unlikely to comply with study visit schedule, significant medical complication)
* Participating in another investigational study that the Investigator believes might interfere with the subject's participation in this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hologic, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Kuslich
Role: STUDY_DIRECTOR
Hologic, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner Health Good Samaritan
Phoenix, Arizona, United States
Dignity Health - St. Joseph's Hospital
Phoenix, Arizona, United States
Advanced Rx Clinical Research
Garden Grove, California, United States
High Desert Gastroenterology
Lancaster, California, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Stanford University Medical Center
Palo Alto, California, United States
Inland Empire Liver Foundation
Rialto, California, United States
Kaiser Permanente
San Diego, California, United States
Kaiser Foundation Hospital
San Francisco, California, United States
San Jose Gastroenterology
San Jose, California, United States
South Bay Gastroenterology Medical Group
Torrance, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Schiff Center for Liver Disease
Miami, Florida, United States
Digestive Healthcare of Georgia
Atlanta, Georgia, United States
Gastrointestinal Specialists of Georgia
Marietta, Georgia, United States
Mercy Medical Center
Baltimore, Maryland, United States
Digestive Disease Associates, PA
Catonsville, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Newton-Wellesley Hospital
Newton, Massachusetts, United States
The Research Institute
Springfield, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
University of Medicine and Dentistry of New Jersey
Newark, New Jersey, United States
Sing Chan, MD
Flushing, New York, United States
North Shore University Hospital
Manhasset, New York, United States
Carolinas HealthCare System
Charlotte, North Carolina, United States
Piedmont HealthCare
Statesville, North Carolina, United States
Integris Baptist Medical Center
Oklahoma City, Oklahoma, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Einstein Healthcare Network
Philadelphia, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Nashville Medical Research Institute
Nashville, Tennessee, United States
Austin Center for Clinical Research
Austin, Texas, United States
Kelsey Research Foundation
Houston, Texas, United States
Liver Associates of Texas
Houston, Texas, United States
University of Utah School of Medicine
Salt Lake City, Utah, United States
Digestive and Liver Disease Specialists
Norfolk, Virginia, United States
Harborview Medical Center
Seattle, Washington, United States
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Napean Hospital, Gastroenterology and Hepatology Department
Kingswood, New South Wales, Australia
Liverpool Hospital, Department of Gastroenterology
Sydney, New South Wales, Australia
St Vincent's Hospital Department of Gastroenterology
Fitzroy, Victoria, Australia
UMHAT Dr. Gerogi Stranski, Clinic of Gastroenterology
Pleven, , Bulgaria
UMHAT Aleksandrovska, Clinic of Gastroenterology
Sofia, , Bulgaria
UMHAT Sveti Ivan Rilski Clinic of Gastroenterology
Sofia, , Bulgaria
Foothills Medical Centre
Calgary, Alberta, Canada
Lair Centre
Vancouver, British Columbia, Canada
University of British Columbia
Vancouver, British Columbia, Canada
GI Research Institute
Vancouver, British Columbia, Canada
London Health Sciences Centre
London, Ontario, Canada
Toronto Liver Centre
Toronto, Ontario, Canada
Leberzentrum am Checkpoint Fachärztegemeinschaft für innere Krankheiten
Berlin, , Germany
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie
Berlin, , Germany
Zentrum für Infektiologie Berlin Prenzlauer Berg
Berlin, , Germany
Universitätsklinikum Essen Klinik für Gastroenterologie und Hepatologie
Essen, , Germany
ifi-Studien und Projekte GmbH An der Asklepios Klinik St. Georg, Haus L
Hamburg, , Germany
ifi-Studien und Projekte GmbH, An der Asklepios Klinik St. Georg
Hamburg, , Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, , Germany
Universitätsmedizin Mannheim II. Medizinische Klinik
Mannheim, , Germany
Szent István és Szent László Kórház
Budapest, , Hungary
Budai Hepatollógiai Központ
Budapest, , Hungary
Szent János Kórház
Budapest, , Hungary
Budai Hepatollógiai Központ
Budapest, , Hungary
Szent János Kórház
Budapest, , Hungary
Pándy Kálmán Megyei Kórház
Gyula, , Hungary
'Ospdale Da Procida
Salerno, , Italy
'Medicina Interna - Ospedale Civile
Sassari, , Italy
Medicina Interna - Ospedale Civile
Sassari, , Italy
Auckland Liver Research Unit
Grafton, Auckland, New Zealand
Waikato Gastroenterology and Respiratory Research Office
Hamilton West, Waikato Region, New Zealand
Gastroenterology Research, Wellington Hospital
Newton, Wellington Region, New Zealand
Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"
Sector 1, București, Romania
Institutul de Boli Infectioase "Prof. Dr. Matei Bals"
Sector 2, București, Romania
Institutul Clinic Fundeni, Bucuresti
Sector 2, București, Romania
Spitalul Universitar de Urgenta Bucuresti
Sector 5, București, Romania
Spitalul Clininc de Boli Infecţioase Constanţa
Constanța, Constanța County, Romania
Spitalul Clinic Judetean de Urgenta Sibiu
Sibiu, Jud. Sibiu, Romania
Policlinica Algomed, Timisoara
Timișoara, Jud. Timis, Romania
Istanbul University Cerrahpaşa School of Medicine
Istanbul, Istanbul, Turkey (Türkiye)
Ankara University School of Medicine
Ankara, , Turkey (Türkiye)
Yıldırım Beyazıt University Atatürk Training and Research Hospital
Ankara, , Turkey (Türkiye)
Adnan Menderes Üniversitesi
Aydin, , Turkey (Türkiye)
Uludag University School of Medicine
Bursa, , Turkey (Türkiye)
Dicle University School of Medicine
Diyarbakır, , Turkey (Türkiye)
Osmangazi University School of Medicine
Eskişehir, , Turkey (Türkiye)
Istanbul University Istanbul School of Medicine
Istanbul, , Turkey (Türkiye)
Dokuz Eylül University School of Medicine
Izmir, , Turkey (Türkiye)
Kocaeli University School of Medicine
Kocaeli, , Turkey (Türkiye)
Selçuk University School of Medicine
Konya, , Turkey (Türkiye)
Ondokuz Mayıs University School of Medicine
Samsun, , Turkey (Türkiye)
Karadeniz Technical University School of Medicine
Trabzon, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V10434-HBVQPS-CSP-01
Identifier Type: OTHER
Identifier Source: secondary_id
V10434-HBVQPS-CSP-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.